NDC product
Lidocaine 4% Patch
NDC 70512-812 · SOLA Pharmaceuticals
Key facts
| Product NDC | 70512-812 |
|---|---|
| Proprietary name | Lidocaine 4% Patch |
| Nonproprietary name | Lidocaine 4% |
| Substances | LIDOCAINE |
| Dosage form | PATCH |
| Route | TOPICAL |
| Labeler | SOLA Pharmaceuticals |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | 505G(a)(3) |
| Pharmacologic classes | Amide Local Anesthetic [EPC], Amides [CS], Antiarrhythmic [EPC], Local Anesthesia [PE] |
| Marketing start | Oct 12, 2023 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: